BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.
Sun Q, Cai D, Liu D, Zhao X, Li R, Xu W, Xie B, Gou M, Wei K, Li Y, Huang J, Chi X, Wei P, Hao J, Guo X, Pan B, Fu Y, Ni L, Dong C.
Sun Q, et al.
Sci Immunol. 2023 Oct 27;8(88):eadh1306. doi: 10.1126/sciimmunol.adh1306. Epub 2023 Oct 20.
Sci Immunol. 2023.
PMID: 37862431